Search tips
Search criteria 


Logo of jcinvestThe Journal of Clinical Investigation
J Clin Invest. 1987 April; 79(4): 1062–1069.
PMCID: PMC424284

Differential effects of hyperinsulinemia and hyperaminoacidemia on leucine-carbon metabolism in vivo. Evidence for distinct mechanisms in regulation of net amino acid deposition.


The effects of physiologic hyperinsulinemia and hyperaminoacidemia, alone or in combination, on leucine kinetics in vivo were studied in postabsorptive healthy subjects with primed-constant infusions of L-[4,5-3H]leucine and [1-14C]alpha-ketoisocaproate (KIC) under euglycemic conditions. Hyperinsulinemia (approximately 100 microU/ml) decreased (P less than 0.05 vs. baseline) steady state Leucine + KIC rates of appearance (Ra) from proteolysis, KIC (approximately leucine-carbon) oxidation, and nonoxidized leucine-carbon flux (leucine----protein). Hyperaminoacidemia (plasma leucine, 210 mumol/liter), with either basal hormone replacement or combined to hyperinsulinemia, resulted in comparable increases in leucine + KIC Ra, KIC oxidation, and leucine----protein (P less than 0.05 vs. baseline). However, endogenous leucine + KIC Ra was suppressed only with the combined infusion. Therefore, on the basis of leucine kinetic data, hyperinsulinemia and hyperaminoacidemia stimulated net protein anabolism in vivo by different mechanisms. Hyperinsulinemia decreased proteolysis but did not stimulate leucine----protein. Hyperaminoacidemia per se stimulated leucine----protein but did not suppress endogenous proteolysis. When combined, they had a cumulative effect on net leucine deposition into body protein.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.4M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Cahill GF., Jr The Banting Memorial Lecture 1971. Physiology of insulin in man. Diabetes. 1971 Dec;20(12):785–799. [PubMed]
  • Greenberg GR, Marliss EB, Anderson GH, Langer B, Spence W, Tovee EB, Jeejeebhoy KN. Protein-sparing therapy in postoperative patients. Effects of added hypocaloric glucose or lipid. N Engl J Med. 1976 Jun 24;294(26):1411–1416. [PubMed]
  • Mortimore GE, Mondon CE. Inhibition by insulin of valine turnover in liver. Evidence for a general control of proteolysis. J Biol Chem. 1970 May 10;245(9):2375–2383. [PubMed]
  • Jefferson LS, Li JB, Rannels SR. Regulation by insulin of amino acid release and protein turnover in the perfused rat hemicorpus. J Biol Chem. 1977 Feb 25;252(4):1476–1483. [PubMed]
  • Hutson SM, Zapalowski C, Cree TC, Harper AE. Regulation of leucine and alpha-ketoisocaproic acid metabolism in skeletal muscle. Effects of starvation and insulin. J Biol Chem. 1980 Mar 25;255(6):2418–2426. [PubMed]
  • Morgan HE, Earl DC, Broadus A, Wolpert EB, Giger KE, Jefferson LS. Regulation of protein synthesis in heart muscle. I. Effect of amino acid levels on protein synthesis. J Biol Chem. 1971 Apr 10;246(7):2152–2162. [PubMed]
  • Woodside KH, Mortimore GE. Suppression of protein turnover by amino acids in the perfused rat liver. J Biol Chem. 1972 Oct 25;247(20):6474–6481. [PubMed]
  • Abumrad NN, Jefferson LS, Rannels SR, Williams PE, Cherrington AD, Lacy WW. Role of insulin in the regulation of leucine kinetics in the conscious dog. J Clin Invest. 1982 Nov;70(5):1031–1041. [PMC free article] [PubMed]
  • Tessari P, Nosadini R, Trevisan R, De Kreutzenberg SV, Inchiostro S, Duner E, Biolo G, Marescotti MC, Tiengo A, Crepaldi G. Defective suppression by insulin of leucine-carbon appearance and oxidation in type 1, insulin-dependent diabetes mellitus. Evidence for insulin resistance involving glucose and amino acid metabolism. J Clin Invest. 1986 Jun;77(6):1797–1804. [PMC free article] [PubMed]
  • Fukagawa NK, Minaker KL, Rowe JW, Goodman MN, Matthews DE, Bier DM, Young VR. Insulin-mediated reduction of whole body protein breakdown. Dose-response effects on leucine metabolism in postabsorptive men. J Clin Invest. 1985 Dec;76(6):2306–2311. [PMC free article] [PubMed]
  • Tessari P, Tsalikian E, Schwenk WF, Nissen SL, Haymond MW. Effects of [15N]leucine infused at low rates on leucine metabolism in humans. Am J Physiol. 1985 Jul;249(1 Pt 1):E121–E130. [PubMed]
  • Nissen SL, Van Huysen C, Haymond MW. Measurement of branched chain amino acids and branched chain alpha-ketoacids in plasma by high-performance liquid chromatography. J Chromatogr. 1982 Oct 8;232(1):170–175. [PubMed]
  • Golden MH, Waterlow JC. Total protein synthesis in elderly people: a comparison of results with [15N]glycine and [14C]leucine. Clin Sci Mol Med. 1977 Sep;53(3):277–288. [PubMed]
  • Clemens AH, Hough DL, D'Orazio PA. Development of the Biostator Glucose clamping algorithm. Clin Chem. 1982 Sep;28(9):1899–1904. [PubMed]
  • Abumrad NN, Rabin D, Diamond MP, Lacy WW. Use of a heated superficial hand vein as an alternative site for the measurement of amino acid concentrations and for the study of glucose and alanine kinetics in man. Metabolism. 1981 Sep;30(9):936–940. [PubMed]
  • DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979 Sep;237(3):E214–E223. [PubMed]
  • Herbert V, Lau KS, Gottlieb CW, Bleicher SJ. Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab. 1965 Oct;25(10):1375–1384. [PubMed]
  • Schwenk WF, Beaufrere B, Haymond MW. Use of reciprocal pool specific activities to model leucine metabolism in humans. Am J Physiol. 1985 Dec;249(6 Pt 1):E646–E650. [PubMed]
  • Beaufrere B, Tessari P, Cattalini M, Miles J, Haymond MW. Apparent decreased oxidation and turnover of leucine during infusion of medium-chain triglycerides. Am J Physiol. 1985 Aug;249(2 Pt 1):E175–E182. [PubMed]
  • James WP, Garlick PJ, Sender PM, Waterlow JC. Studies of amino acid and protein metabolism in normal man with L-[U-14C]tyrosine. Clin Sci Mol Med. 1976 Jun;50(6):525–532. [PubMed]
  • Tessari P, Nissen SL, Miles JM, Haymond MW. Inverse relationship of leucine flux and oxidation to free fatty acid availability in vivo. J Clin Invest. 1986 Feb;77(2):575–581. [PMC free article] [PubMed]
  • Schneible PA, Airhart J, Low RB. Differential compartmentation of leucine for oxidation and for protein synthesis in cultured skeletal muscle. J Biol Chem. 1981 May 25;256(10):4888–4894. [PubMed]
  • Tessari P, Inchiostro S, Biolo G, Duner E, Nosadini R, Tiengo A, Crepaldi G. Hyperaminoacidaemia reduces insulin-mediated glucose disposal in healthy man. Diabetologia. 1985 Nov;28(11):870–872. [PubMed]
  • Robert JJ, Bier DM, Zhao XH, Matthews DE, Young VR. Glucose and insulin effects on the novo amino acid synthesis in young men: studies with stable isotope labeled alanine, glycine, leucine, and lysine. Metabolism. 1982 Dec;31(12):1210–1218. [PubMed]
  • Tessari P, Trevisan R, Inchiostro S, Biolo G, Nosadini R, De Kreutzenberg SV, Duner E, Tiengo A, Crepaldi G. Dose-response curves of effects of insulin on leucine kinetics in humans. Am J Physiol. 1986 Sep;251(3 Pt 1):E334–E342. [PubMed]
  • Mortimore GE, Woodside KH, Henry JE. Compartmentation of free valine and its relation to protein turnover in perfused rat liver. J Biol Chem. 1972 May 10;247(9):2776–2784. [PubMed]
  • Katz J. Importance of sites of tracer administration and sampling in turnover studies. Fed Proc. 1982 Jan;41(1):123–128. [PubMed]
  • Nair KS, Garrow JS, Ford C, Mahler RF, Halliday D. Effect of poor diabetic control and obesity on whole body protein metabolism in man. Diabetologia. 1983 Nov;25(5):400–403. [PubMed]
  • Buse MG, Biggers JF, Drier C, Buse JF. The effect of epinephrine, glucagon, and the nutritional state on the oxidation of branched chain amino acids and pyruvate by isolated hearts and diaphragms of the rat. J Biol Chem. 1973 Jan 25;248(2):697–706. [PubMed]
  • Buse MG, Reid SS. Leucine. A possible regulator of protein turnover in muscle. J Clin Invest. 1975 Nov;56(5):1250–1261. [PMC free article] [PubMed]
  • Freund H, Yoshimura N, Lunetta L, Fischer JE. The role of the branched-chain amino acids in decreasing muscle catabolism in vivo. Surgery. 1978 Jun;83(6):611–618. [PubMed]
  • Marchesini G, Zoli M, Dondi C, Bianchi G, Cirulli M, Pisi E. Anticatabolic effect of branched-chain amino acid-enriched solutions in patients with liver cirrhosis. Hepatology. 1982 Jul-Aug;2(4):420–425. [PubMed]

Articles from The Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation